{"api":"v1","generated_at":"2026-10-03T23:07:15.401Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-r-iss-a72a0f","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-r-iss-a72a0f/at/2026-10-03T21-12Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-03T21:12:52.186Z","snapshot_stamp":"2026-10-03T21-12Z","endpoint":{"slug":"api-magentlab-com-api-calc-r-iss-a72a0f","canonical_url":"https://api.magentlab.com/api/calc/r_iss","resource":"https://api.magentlab.com/api/calc/r_iss","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Palumbo 2015 R-ISS for multiple myeloma. ISS from beta-2 microglobulin and albumin (Greipp 2005). R-ISS I: ISS I, standard-risk iFISH CA, and normal LDH. R-ISS III: ISS III plus high-risk CA (del(17p) and/or t(4;14) and/or t(14;16)) or LDH > ULN. R-ISS II: all other combinations. Not a myeloma diagnosis or treatment choice; not R2-ISS; not Durie-Salmon. magent does not assay beta-2 microglobulin, albumin, LDH, or cytogenetics.","service_name":"magent","declared_category":null,"declared_tags":["r-iss","myeloma","hematology","staging","calculator"],"route_template":null,"registry_updated":"2026-09-28T15:12:47.557Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc r iss","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-03T21:12:52.185Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-03T21:12:52.186Z","calls_30d":1,"unique_payers_30d":1,"last_called_at":"2026-09-28T15:12:47.400Z"},"validation":{"latest":{"observed_at":"2026-10-03T06:53:56.468Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-03"},"uptime":[{"days":7,"observed":7,"passed":7,"ratio":1},{"days":30,"observed":7,"passed":7,"ratio":1},{"days":90,"observed":7,"passed":7,"ratio":1}],"history_90d":[{"observed_at":"2026-10-03T06:53:56.468Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-03","state_changed":false},{"observed_at":"2026-10-02T16:04:19.767Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-02","state_changed":false},{"observed_at":"2026-10-01T08:51:10.890Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T08:15:24.314Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T20:25:04.751Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T17:33:22.355Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:46:36.328Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["r-iss","myeloma","hematology","staging","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/r_iss","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T15:12:47.4Z","l30DaysTotalCalls":1,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/r_iss","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"ldh_gt_uln":false,"albumin_g_l":40,"albumin_g_dl":4,"high_risk_ca":false,"beta2_microglobulin_mg_l":2},{"ldh_gt_uln":false,"albumin_g_l":40,"albumin_g_dl":4,"high_risk_ca":false,"beta2_microglobulin_mg_l":2}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/r_iss","count":2,"items":[{"formula":"r_iss","citation":{"id":"palumbo-2015","doi":"10.1200/JCO.2015.61.2267","pmid":"26240224","title":"Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group","source":"J Clin Oncol. 2015;33(26):2863-2869","authors":"Palumbo A, Avet-Loiseau H, Oliva S, et al."},"iss_stage":1,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","ldh_gt_uln":false,"riss_stage":1,"albumin_g_dl":4,"high_risk_ca":false,"iss_stage_label":"I","riss_stage_label":"I","formula_expression":"R-ISS I: ISS I AND high_risk_ca false AND ldh_gt_uln false; R-ISS III: ISS III AND (high_risk_ca OR ldh_gt_uln); R-ISS II: all other combinations. ISS I: beta2_microglobulin_mg_l < 3.5 AND albumin_g_dl >= 3.5; ISS III: beta2_microglobulin_mg_l >= 5.5; ISS II: neither I nor III (Palumbo 2015; ISS as Greipp 2005)","beta2_microglobulin_mg_l":2},{"formula":"r_iss","citation":{"id":"palumbo-2015","doi":"10.1200/JCO.2015.61.2267","pmid":"26240224","title":"Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group","source":"J Clin Oncol. 2015;33(26):2863-2869","authors":"Palumbo A, Avet-Loiseau H, Oliva S, et al."},"iss_stage":1,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","ldh_gt_uln":false,"riss_stage":1,"albumin_g_dl":4,"high_risk_ca":false,"iss_stage_label":"I","riss_stage_label":"I","formula_expression":"R-ISS I: ISS I AND high_risk_ca false AND ldh_gt_uln false; R-ISS III: ISS III AND (high_risk_ca OR ldh_gt_uln); R-ISS II: all other combinations. ISS I: beta2_microglobulin_mg_l < 3.5 AND albumin_g_dl >= 3.5; ISS III: beta2_microglobulin_mg_l >= 5.5; ISS II: neither I nor III (Palumbo 2015; ISS as Greipp 2005)","beta2_microglobulin_mg_l":2}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["beta2_microglobulin_mg_l","high_risk_ca","ldh_gt_uln"],"properties":{"ldh_gt_uln":{"type":"boolean","description":"Serum LDH greater than the upper limit of normal as assigned by the caller (Palumbo 2015: high LDH is > ULN). magent does not assay LDH or assign ULN."},"albumin_g_l":{"type":"number","description":"Serum albumin in g/L (10-60). Converted as g/dL = g/L / 10. Provide this or albumin_g_dl, not both."},"albumin_g_dl":{"type":"number","description":"Serum albumin in g/dL (1-6). Provide this or albumin_g_l, not both. ISS uses g/dL. Stage I requires albumin >= 3.5 when Sβ2M < 3.5. Ignored when Sβ2M >= 5.5."},"high_risk_ca":{"type":"boolean","description":"High-risk cytogenetic abnormalities as assigned by the caller: true iff del(17p) and/or t(4;14) and/or t(14;16) by iFISH (Palumbo 2015). magent does not FISH."},"beta2_microglobulin_mg_l":{"type":"number","description":"Serum beta-2 microglobulin in mg/L (0.2-40). Greipp 2005 / Palumbo 2015 ISS. Stage I requires < 3.5; stage III when >= 5.5. magent does not assay beta-2 microglobulin."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Palumbo 2015 R-ISS for multiple myeloma. ISS from beta-2 microglobulin and albumin (Greipp 2005). R-ISS I: ISS I, standard-risk iFISH CA, and normal LDH. R-ISS III: ISS III plus high-risk CA (del(17p) and/or t(4;14) and/or t(14;16)) or LDH > ULN. R-ISS II: all other combinations. Not a myeloma diagnosis or treatment choice; not R2-ISS; not Durie-Salmon. magent does not assay beta-2 microglobulin, albumin, LDH, or cytogenetics.","lastUpdated":"2026-09-28T15:12:47.557Z","serviceName":"magent","x402Version":2}]}}